Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss and Pipeline Progress Support Positive Market Reaction GDYN Q1 2026 Earnings EPS Beats Estimates on Improved Operational Efficiency CAE Q1 2026 Earnings EPS Beat of 122 Amid Stock Decline Saga Q1 2026 Earnings Negative EPS and Stock Decline Amidst Industry Headwinds CFBK Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher IFRX Q4 2025 Earnings NarrowerThanExpected Loss Supports Stock Rally